You have 3 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neoplasms, Plasma Cell

Showing 76 - 100 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Suzhou (Tocilizumab)

Recruiting
  • Multiple Myeloma
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 3, 2023

Relapsed or Refractory Multiple Myeloma Trial (Forimtamig, Carfilzomib, Daratumumab)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • (no location specified)
Sep 20, 2023

Multiple Myeloma, Smoldering Multiple Myeloma Trial in Boston (liquid biopsy)

Recruiting
  • Multiple Myeloma
  • liquid biopsy
  • Norwalk, Connecticut
  • +1 more
Jan 9, 2023

Real-world Usage of HyQvia in Multiple Myeloma Secondary

Not yet recruiting
  • Multiple Myeloma
  • Secondary Immunodeficiency (SID)
  • No Intervention
  • (no location specified)
May 19, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Duarte (Actinium Ac 225-DOTA-Daratumumab, Daratumumab,

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Actinium Ac 225-DOTA-Daratumumab
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Multiple Myeloma Trial (Dexamethasone, Isatuximab, Lenalidomide)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Jan 10, 2023

Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

Recruiting
  • Multiple Myeloma in Remission
  • MM-specific universal CAR T cells
  • Shenzhen, Guangdong, China
  • +1 more
Aug 23, 2023

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

Active, not recruiting
Has Results
  • Advanced Lymphoma
  • +5 more
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta (Tocilizumab, Venetoclax)

Recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 24, 2023

Plasma Cell Myeloma Trial in New Brunswick (Loratadine, Placebo, Questionnaire Administration)

Recruiting
  • Plasma Cell Myeloma
  • New Brunswick, New Jersey
  • +1 more
Oct 17, 2022

Relapsed and/or Refractory Multiple Myeloma Trial in Köln (BMS-986453, Fludarabine, Cyclophosphamide)

Not yet recruiting
  • Relapsed and/or Refractory Multiple Myeloma
  • Köln, Germany
    Local Institution - 0017
Dec 4, 2023

Immunotherapy, Multiple Myeloma Trial in Zhengzhou (Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK))

Recruiting
  • Immunotherapy
  • Multiple Myeloma
  • Chimeric Antigen Receptor NK Cell Injection Targeting BCMA (BCMA CAR-NK)
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Dec 14, 2022

Multiple Myeloma Trial in Rochester (behavioral, other, procedure)

Not yet recruiting
  • Multiple Myeloma
  • Supportive Care (home-based physical activity)
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 22, 2023

Refractory Multiple Myeloma, Relapse Multiple Myeloma, Multiple Myeloma Trial in Boston (Elranatamab)

Not yet recruiting
  • Refractory Multiple Myeloma
  • +2 more
  • Boston, Massachusetts
  • +2 more
Nov 17, 2023

Multiple Myeloma Trial (Melphalan and Treosulfan, Melphalan)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Dec 5, 2022

Relapsed/Refractory Multiple Myeloma Trial in Suzhou (ICI201)

Not yet recruiting
  • Relapsed/Refractory Multiple Myeloma
  • Suzhou, Jiangsu, China
    First Affiliated Hospital, Soochow University
Jul 31, 2023

Quality of Life in Asymptomatic Monoclonal Gammopathies

Recruiting
  • Monoclonal Gammopathy of Undetermined Significance
  • Smoldering Plasma Cell Myeloma
  • Quality-of-Life Assessment
  • Questionnaire Administration
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Myeloma Novel Drug Discovery Ver 1.2

Recruiting
  • Multiple Myeloma
  • Observational study - sample collection only.
  • London Borough of Sutton, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 1, 2023

Health Technology Intervention on Patient Activation in Multiple

Not yet recruiting
  • Multiple Myeloma in Relapse
  • +3 more
    • (no location specified)
    Jan 9, 2023

    Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

    Active, not recruiting
    • Advanced Lymphoma
    • +5 more
    • Trametinib Dimethyl Sulfoxide
    • Philadelphia, Pennsylvania
      ECOG-ACRIN Cancer Research Group
    Aug 13, 2022

    Multiple Myeloma Trial in Salt Lake City (Budesonide EC, Placebo)

    Not yet recruiting
    • Multiple Myeloma
    • Budesonide EC
    • Placebo
    • Salt Lake City, Utah
      Huntsman Cancer Institute at the University of Utah
    Jan 9, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma, Relapsed or Refractory Multiple Myeloma Trial in Changsha (BEBT-908 for

    Completed
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Relapsed or Refractory Multiple Myeloma
    • BEBT-908 for injection
    • Changsha, Hunan, China
      Hunan Cancer Hospital
    Oct 9, 2023

    Multiple Myeloma Trial in New York (Circadian Effective Lighting, Circadian Ineffective Lightning (CIL))

    Recruiting
    • Multiple Myeloma
    • Circadian Effective Lighting
    • Circadian Ineffective Lightning (CIL)
    • New York, New York
    • +1 more
    Feb 10, 2023

    Smoldering Multiple Myeloma Trial in Rochester (Denosumab)

    Active, not recruiting
    • Smoldering Multiple Myeloma
    • Rochester, New York
      University of Rochester
    Oct 3, 2022

    Relapsed/Refractory Multiple Myeloma Trial in Benowa (ISB 2001)

    Not yet recruiting
    • Relapsed/Refractory Multiple Myeloma
    • ISB 2001
    • Benowa, Queensland, Australia
      Pindara Private Hospital
    May 18, 2023